Veru Inc. VERU
NASDAQ VERU
$2.14 +0.02 (+0.94%)
At close: Nov 11, 2026 · 4:00 PM EST

Veru (VERU) Capital Leases (2009 - 2011)

Updated

Veru (VERU) reported Capital Leases of $12,999 for fiscal Q4 2010 (quarter ended Sep 30, 2010).

Analysis

Veru (VERU) Capital Leases (2009 - 2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Veru 48.87 Mn -61.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2011 4,660.00
Dec 31, 2010 8,659.00
Sep 30, 2010 12,999.00
Jun 30, 2010 16,254.00
Mar 31, 2010 20,016.00
Dec 31, 2009 27,406.00
Sep 30, 2009 34,428.00
Jun 30, 2009 51,095.00
Mar 31, 2009 23,102.00
API Access

Veru Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=VERU&period=max&api_key=YOUR_API_KEY